News | December 22, 2025
CORONA Remedies commissions additional capacity
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The additional production will raise the installed capacity by 400 million and available capacity by 240 million at the facility
The MAR-Autism Test represents more than 20 years of research at the UC Davis MIND Institute by Judy Van de Water
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
Hansoh Pharma will receive an upfront payment in the low double-digit millions
Her journey includes leading HR for large and diverse teams across sales, marketing, corporate functions, and R&D
The positive CHMP opinion is supported by results from the Phase III QUASAR trial
The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Zylet Ophthalmic Suspension, 0.5%/0.3%, of Bausch & Lomb
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
The multi-partner team will integrate new technologies across the entire mAb production workflow, from cell line development to purification
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
